Trial Profile
To investigate the efficacy, safety and quality of life with treatment of Botulinum toxin type A (BoNT-A) in patients with spasticity - An international, observational, SPACE (SPAsticity in practiCE) study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- Acronyms SPACE
- Sponsors Merz Pharmaceuticals GmbH
- 14 Sep 2016 New trial record